Data mining in spontaneous reports
- PMID: 16611210
- DOI: 10.1111/j.1742-7843.2006.pto_232.x
Data mining in spontaneous reports
Abstract
The increasing size of spontaneous report data sets and the increasing capability for screening such data due to increases in computational power has led to a recent increase in interest and use of data mining on such data. While data mining plays an important role in the analysis of spontaneous reports, there is general debate on how and when data mining should be best performed. While the cornerstone principles for data mining of spontaneous reports have been in place since the 1960s, several significant changes have occurred to make their use widespread. Superficially the Bayesian methods seem unnecessarily complex, particularly given the nature of the data, but in practice implementation in Bayesian framework gives clear benefits. There are difficulties evaluating the performance of the methods, but they work and save resources in managing large data sets. The use of neural networks allows more sophisticated pattern recognition to be performed.
Similar articles
-
Quantitative signal detection using spontaneous ADR reporting.Pharmacoepidemiol Drug Saf. 2009 Jun;18(6):427-36. doi: 10.1002/pds.1742. Pharmacoepidemiol Drug Saf. 2009. PMID: 19358225 Review.
-
Reports of hyperkalemia after publication of RALES--a pharmacovigilance study.Pharmacoepidemiol Drug Saf. 2006 Nov;15(11):775-83. doi: 10.1002/pds.1275. Pharmacoepidemiol Drug Saf. 2006. PMID: 16804951
-
The application of knowledge discovery in databases to post-marketing drug safety: example of the WHO database.Fundam Clin Pharmacol. 2008 Apr;22(2):127-40. doi: 10.1111/j.1472-8206.2007.00552.x. Epub 2008 Feb 1. Fundam Clin Pharmacol. 2008. PMID: 18248442 Review.
-
Comparison of data mining methodologies using Japanese spontaneous reports.Pharmacoepidemiol Drug Saf. 2004 Jun;13(6):387-94. doi: 10.1002/pds.964. Pharmacoepidemiol Drug Saf. 2004. PMID: 15170768
-
Comparison of recent methods for inference of variable influence in neural networks.Neural Netw. 2006 May;19(4):500-13. doi: 10.1016/j.neunet.2005.09.002. Epub 2005 Dec 13. Neural Netw. 2006. PMID: 16352417
Cited by
-
Illusions of objectivity and a recommendation for reporting data mining results.Eur J Clin Pharmacol. 2007 May;63(5):517-21. doi: 10.1007/s00228-007-0279-3. Epub 2007 Mar 16. Eur J Clin Pharmacol. 2007. PMID: 17364192
-
Prospective data mining of six products in the US FDA Adverse Event Reporting System: disposition of events identified and impact on product safety profiles.Drug Saf. 2010 Feb 1;33(2):139-46. doi: 10.2165/11319000-000000000-00000. Drug Saf. 2010. PMID: 20082540
-
Sources of Safety Data and Statistical Strategies for Design and Analysis: Postmarket Surveillance.Ther Innov Regul Sci. 2018 Mar;52(2):159-169. doi: 10.1177/2168479017741112. Epub 2018 Jan 8. Ther Innov Regul Sci. 2018. PMID: 29714520 Free PMC article. Review.
-
Controlled trials and risk of harm.Drug Saf. 2008;31(11):961-3. doi: 10.2165/00002018-200831110-00001. Drug Saf. 2008. PMID: 18840016 No abstract available.
-
'Extreme duplication' in the US FDA Adverse Events Reporting System database.Drug Saf. 2007;30(6):551-4. doi: 10.2165/00002018-200730060-00009. Drug Saf. 2007. PMID: 17536881 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical